UPCOMING WEBSITE MAINTENANCE NOTICE - Please be aware that our website will be temporarily unavailable on Tuesday 6th August from 06:00 – 07:00 am UTC. If you need assistance during this time, please contact our customer support team at Halo.CRM@euromonitorint.onmicrosoft.com.
Understand the cultural and socioeconomic influences that shape industry demand throughout Asia-Pacific, with local insight, market statistics and analysis ranging from strategic regional overview to in-depth coverage by country or city.
Understand the cultural and socioeconomic influences that shape i...
Understand the cultural and socioeconomic influences that shape industry demand throughout Asia-Pacific, with local insight, market statistics and analysis ranging from strategic regional overview to in-depth coverage by country or city.
Cough, cold and allergy (hay fever) remedies is experiencing a level of stabilisation in 2023. Following strong retail volume growth in the wake of the Coronavirus (COVID-19) pandemic, almost all categories are projected to see slower retail volume…
Sales of cough, cold and allergy (hay fever) remedies in Japan have continued to recover in 2023. This is largely due to increased opportunities for consumers to go out and a shift away from the practice of wearing face masks on a daily basis. With…
Although the pandemic is considered over, this is not expected to immediately reduce sales of OTC cough and cold medicines in Indonesia in 2023, with both retail volume and current value growth set to continue across most categories. However, the…
In 2023, cough, cold, and allergy (hay fever) remedies in India is set to experience moderate single-digit current value growth, driven predominantly by the demand for decongestants. Decongestants is expected to demonstrate above-average growth due…
The removal of mask-wearing and social distancing measures in March 2023 led to rising demand for cough, cold and allergy remedies as respiratory infections increased. Since February 2020, local seasonal influenza in Hong Kong has remained at a low…